International pharmaceutical company Galderma has increased its investment in research and innovation, initiating six new Phase III and IV US aesthetic clinical trials.
Facial injectables market to be worth $17.2 billion by 2025
The British Association of Dermatologists (BAD) has released statistics indicating that during COVID-19, 59% of healthcare workers seen in occupational skin disease clinics have been affected by irritant contact dermatitis, due to increased PPE use and frequent hand washing.
Financial services company SunLife has conducted a study which suggests that there is an increasing amount of Britons over the age of 50 feeling under pressure to stay looking young.
A study published in JAMA Dermatology has indicated that increased caffeine intake from coffee is inversely associated with the risk of rosacea in women.
According to a new study, a combination of adapalene 0.3% and benzoyl peroxide 2.5% gel (A/BPO) has indicated to be superior to a vehicle for the treatment of severe acne.
A study published in the American Journal of Clinical Nutrition has indicated that vitamin D2 and D3 do not have the same nutritional value.
On Wednesday March 20, the online resource for patients with skin of colour, Black Skin Directory, hosted an educational skincare event teaching patients about skincare options and treatments most suited to darker skin tones.
Global pharmaceutical company Almirall has collaborated with research group Nanomol, of the Institute of Material Science of Barcelona from the Spanish National Research Council (ICMAB-CSIC), and the Leitat Technology Centre of Nanomedicine to conduct a research project.
The International Society of Aesthetic Plastic Surgery (ISAPS) has released the results of the second International Study of Aesthetic/Cosmetic Surgery Procedures.